Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × zanidatamab × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Stomach Neoplasms 3 Colorectal Neoplasms 3 Esophageal Neoplasms 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Muscle Invasive Bladder Cancer (MIBC) 1 Hemangiosarcoma 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Advanced Malignancies 1

Interventions

pembrolizumab 18 Radiotherapy 10 Cisplatin 10 Carboplatin 9 Cetuximab 8 Paclitaxel 7 Drug Therapy 4 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 Docetaxel 3 toripalimab 2 tislelizumab 2 palbociclib 2 osimertinib 2 fludarabine 2 X-Rays 2 Surveys and Questionnaires 2 Standard of Care 2 Radiation 2 Pravastatin 2 Magnetic Resonance Spectroscopy 2 Ketoprofen 2 Fulvestrant 2 Fluorouracil 2 Equipment and Supplies 2 Cyclophosphamide 2 Chemoradiotherapy 2 Blood Specimen Collection 2 Afatinib 2 ulixertinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡